Altamira Therapeutics to Present at Two Upcoming RNA Therape

New, trends and future of RNA-based therapeuticsCompany's OligoPhoreTM / SemaPhoreTM polyplexes provide for efficient delivery of siRNA payloads into extrahepatic target cellsCompany's latest research

Related Keywords

Bermuda , Boston , Massachusetts , United States , Switzerland , London , City Of , United Kingdom , Samuela Wickline , Covadonga Pa , Schwierige Zeiten , Securities Exchange Commission , Company Oligophore , Company Oligophore Semaphore , Altamira Therapeutics Ltd , Securities Exchange , Nasdaq , Altamira Therapeutics , London February , Based Therapeutics Summit , Boston March , Chief Operating Officer , Chief Scientific Adviser , Pore Forming Peptides , Optimized Endosomal Escape , Delivery With Oligophore , Peptide Based Nanoparticles , Securities Act , Securities Exchange Act , Altamira Therapeutic , Altamira Therapeutic Annual Report , Altamira Therapeuticsview , Altamira , Herapeutics , Present , Pcoming , Conferences , 023 ,